Question 1

Does Ubs own CLGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 1,035 shares of CLGN (Collplant Biotechnologies), worth $361.

Question 2

How many shares of CLGN does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 1,035 shares of CLGN (Collplant Biotechnologies).

Question 3

What is Ubs' CLGN position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' CLGN position is worth $361.

Question 4

Is Ubs buying or selling CLGN?

Accepted Answer

In Q2 2026, Ubs increased its CLGN position from 95 to 1,035 shares.

Question 5

When did Ubs first buy CLGN?

Accepted Answer

Ubs first reported CLGN in its Q2 2021 13F and has listed it in 16 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1,035	+989.5%	$361	0.0%	$0.35	12
2026-Q1	New	95	-	$51	0.0%	$0.57	17
2025-Q2	Exited	0	-100.0%	$0	0.0%	$1.38	0
2025-Q1	Increased	24,074	+8.4%	$62,111	0.0%	$2.55	15
2024-Q4	Increased	22,208	+85.9%	$79,949	0.0%	$3.63	23
2024-Q3	Increased	11,947	+67.3%	$59,317	0.0%	$4.93	21

CLGNShowing 6 of 19 quarters

CLGN
Showing 6 of 19 quarters